Citadel Advisors’s InnovAge Holding INNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.4K Sell
12,400
-2,400
-16% -$17.9K ﹤0.01% 12026
2025
Q4
$76.8K Sell
14,800
-17,600
-54% -$92.5K ﹤0.01% 11822
2025
Q3
$167K Buy
+32,400
New +$131K ﹤0.01% 11445
2025
Q2
Sell
-7,000
Closed -$20.9K 13746
2025
Q1
$20.9K Buy
7,000
+6,400
+1,067% +$22.1K ﹤0.01% 13112
2024
Q4
$2.36K Buy
+600
New +$3.11K ﹤0.01% 14090
2022
Q1
Sell
-27,900
Closed -$140K 14070
2021
Q4
$140K Buy
+27,900
New +$203K ﹤0.01% 12353

Other funds holding INNV

Citadel Advisors's INNV Position: Q1 2026 in Review

Citadel Advisors sold out of InnovAge Holding (INNV) in Q1 2026, closing a stake of 62,715 shares — an estimated $468K sold.

Citadel Advisors first reported a position in INNV in Q1 2021 and held it in 9 quarters. The position peaked at $13.2M in Q1 2021. 103 funds tracked by Wall St. Rank hold INNV as of Q1 2026.

  • Citadel Advisors reported no remaining InnovAge Holding position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 62,715 InnovAge Holding shares in Q1 2026, an estimated $468K.
  • Citadel Advisors first reported a position in InnovAge Holding in Q1 2021 and held it in 9 quarters.
  • Citadel Advisors's InnovAge Holding position peaked at $13.2M in Q1 2021.
  • 103 funds tracked by Wall St. Rank held InnovAge Holding as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.